Januvia tablets 12.5 mg, manufactured by MSD, contain Sitagliptin phosphate hydrate. This DPP-4 inhibitor is used to improve glycemic control in type 2 diabetes. YJ code: 3969010F4033, standard: 12.5 mg 1 tablet.
Januvia tablets 12.5 mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
